Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Checkmate Pharmaceuticals Inc (CMPI)

Checkmate Pharmaceuticals Inc (CMPI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Help
Go To:
University of Iowa Holden Comprehensive Cancer Center Presents Preliminary Data from Clinical Trial of Vidutolimod at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting Globe Newswire - Thu May 26, 2022

CAMBRIDGE, Mass., May 26, 2022 (GLOBE NEWSWIRE) -- Checkmate Pharmaceuticals, Inc. (NASDAQ: CMPI) (“Checkmate”), a clinical stage biotechnology...

CMPI : 10.50 (+0.19%)
CHECKMATE PHARMACEUTICALS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Checkmate Pharmaceuticals, Inc. - CMPI Business Wire - Tue May 17, 2022

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Checkmate Pharmaceuticals, Inc. (NasdaqGM:...

CMPI : 10.50 (+0.19%)
REGN : 955.76 (-1.46%)
Checkmate Pharmaceuticals Announces First Quarter 2022 Financial Results and Provides Business Update Globe Newswire - Thu May 12, 2022

CAMBRIDGE, Mass., May 12, 2022 (GLOBE NEWSWIRE) -- Checkmate Pharmaceuticals, Inc. (Nasdaq: CMPI) (“Checkmate”), a clinical stage biopharmaceutical...

CMPI : 10.50 (+0.19%)
CHECKMATE PHARMACEUTICALS INVESTOR ALERT by The Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Checkmate Pharmaceuticals, Inc. - CMPI Business Wire - Thu May 5, 2022

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Checkmate Pharmaceuticals, Inc. (NasdaqGM:...

CMPI : 10.50 (+0.19%)
REGN : 955.76 (-1.46%)
Rare Poison Pill Strategy an Oddity Among Premium Price Takeover Bids Flurry BayStreet.ca - Tue Apr 26, 2022

USA News Group – Prior to the recent takeover bid of Twitter Inc. (NYSE:TWTR), by the world’s wealthiest man, Elon Musk, the term “poison pill” was rarely uttered in the market. A quick glance...

RHC.AX : 50.380 (-1.60%)
TWTR : 53.70 (+0.66%)
PQEFF : 0.0001 (unch)
KKR : 99.67 (+0.13%)
CMPI : 10.50 (+0.19%)
REGN : 955.76 (-1.46%)
Biotech Stock Roundup: NKTR Plunges on Deal Termination, REGN Offers Update & More Zacks - Wed Apr 20, 2022

Regulatory and pipeline updates from Nektar (NKTR) and Regeneron (REGN) are a few key highlights from the biotech sector during the past week.

REGN : 955.76 (-1.46%)
BMY : 43.67 (-0.84%)
NKTR : 1.6400 (+9.33%)
AXSM : 75.68 (-1.64%)
CMPI : 10.50 (+0.19%)
Regeneron (REGN) to Buy Checkmate Pharmaceuticals for $250M Zacks - Wed Apr 20, 2022

Regeneron (REGN) is set to acquire Checkmate Pharmaceuticals for $250 million to broaden its portfolio of diverse immuno-oncology candidates.

REGN : 955.76 (-1.46%)
SNY : 50.10 (+1.07%)
BAYRY : 7.6801 (-0.52%)
CMPI : 10.50 (+0.19%)
Why Adaptimmune Therapeutics, Agenus, and Sorrento Therapeutics Popped Today Motley Fool - Tue Apr 19, 2022

Regeneron's buyout of Checkpoint Pharmaceuticals is sparking a rally among clinical-stage cancer research companies today.

ADAP : 1.1400 (+3.64%)
AGEN : 11.47 (-4.50%)
SRNE : 0.0135 (-32.50%)
REGN : 955.76 (-1.46%)
CMPI : 10.50 (+0.19%)
Why Checkmate Pharmaceuticals Stock Is Rocketing Higher Today Motley Fool - Tue Apr 19, 2022

Checkpoint Pharmaceuticals lands a premium-rich buyout offer from biotech heavyweight Regeneron.

CMPI : 10.50 (+0.19%)
REGN : 955.76 (-1.46%)
Author
Why Is Arqit Quantum (ARQQ) Stock Down Today? InvestorPlace - Tue Apr 19, 2022

Former ARQQ employees are calling out the company today

ACC : 65.42 (+0.08%)
CMPI : 10.50 (+0.19%)
ARQQ : 0.4161 (-8.55%)

Barchart Exclusives

2 High-Yield Dividend Stocks to Buy Before Memorial Day Barchart - Wed May 8, 6:30PM CDT
With the forecast calling for strong travel demand this summer, these two dividend-paying stocks stand to benefit from the trend. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot